CO701 Dermatology, Anatomy and Pathophysiology for Clinical Aesthetic Practice (R/651/9194) Assignment Brief 2026

Unit CO701 Dermatology, Anatomy and Pathophysiology for Clinical Aesthetic Practice Assignment Brief

Unit Aim

• This unit is for advanced beauty therapists and aesthetic practitioners to develop applied knowledge and understanding of the anatomical structures of the face, including musculature, innervation, vascular supply, age, gender, and ethnicityrelated anatomical variations.
• Learners will apply this understanding to assess facial characteristics, lines, folds, and volume changes to support safe and effective aesthetic procedures.
• This unit has been developed using the JCCP Competency Framework and the latest national occupational standards (NOS).

Learning Outcomes, and Assessment Criteria

Indicative Content 

Complex Facial Anatomy

• surface anatomy of the face: planes, layers (skin, subcutaneous fat, SMAS, deep fascia, bone)
• muscles of facial expression: origins, insertions, innervations, and actions
• anatomical danger zones: glabella, temple, nasal bridge, infraorbital region
• anatomical variations: age, gender, ethnicity, skin type (Fitzpatrick scale)

Muscles of Facial Expression and Dynamic Rhytids

• dynamic vs static wrinkles
• functional anatomy of muscles contributing to expression lines  upper third of the face: frown lines, forehead lines, crow’s feet
• muscle antagonism and balance in facial aesthetics
• clinical relevance for botulinum toxin injection mapping
• muscles of facial expression (frontalis, orbicularis oculi, zygomaticus major/minor, depressor anguli oris, etc.)
• muscles of mastication (masseter, temporalis, buccinator)
• superficial vs deep musculature
• functional anatomy and relevance to facial animation and ageing

Nerve Supply

• facial nerve (cranial nerve VII): motor branches and distribution
• trigeminal nerve (cranial nerve V): sensory branches (ophthalmic, maxillary, mandibular)
• clinical relevance: sensory landmarks, areas of anaesthesia, nerve injury risks
• implications for neuromodulator (botulinum toxin) placement

Blood Supply

• arterial system: facial, angular, infraorbital, supratrochlear, supraorbital, superficial temporal arteries
• venous system: facial, ophthalmic veins, communication with cavernous sinus, risk of embolism
• identification of high-risk injection zones
• importance of aspiration, slow injection, and cannula use in aesthetics

Skin Health and Pathophysiology

• structure and function of skin layers: epidermis, dermis, hypodermis
• collagen and elastin degradation
• common skin lesions: moles, actinic keratoses, rosacea, acne, dermatitis
• recognising dermal abnormalities and referral red flags
• intrinsic ageing factors: genetics, hormonal changes, cellular senescence
• extrinsic ageing factors: UV exposure, pollution, smoking, alcohol, nutrition, stress
• Fitzpatrick skin types and photoaging patterns
• systemic medications and effects on skin and muscles (e.g., corticosteroids, isotretinoin, anticoagulants, neuromuscular blockers)

Ageing Process and Structural Changes

• chronological vs photoaging
• changes to collagen, elastin, hyaluronic acid, and glycosaminoglycans
• skeletal resorption patterns of the maxilla, mandible, and orbit
• volume loss in fat compartments and muscular atrophy
• changes in facial symmetry, contour, and projection
• clinical implications for aesthetic correction

Facial Characteristics and Variation

• ethnicity: bone structure, skin thickness, pigmentation, and soft tissue variation
• gender: skeletal and soft tissue dimorphism (mandibular width, cheek projection, brow shape)
• age: volume loss, ptosis, dynamic and static lines, skeletal resorption
• skin type: Fitzpatrick I–VI, dermal thickness, oil content, healing response, pigmentation risk

Assessment and Analysis

• facial mapping and symmetry assessment
• identification of dynamic vs static wrinkles
• assessment of mid-face volume and contour
• ageing markers by decade
• patient profiling: integrating anatomy with aesthetic goals
• documentation and consultation techniques

Clinical Safety and Application

• vascular danger zones (glabella, nasolabial fold, temple, nose, infraorbital area)
• safe injection planes (subdermal, intramuscular, supraperiosteal)
• aseptic technique and anatomical justification
• managing complications related to anatomy (vascular occlusion, nerve injury)

Glossary

Anatomical landmarks: fixed points used to locate facial structures accurately

Bone resorption: loss of bone density and volume with age, affecting facial support and contour

Cranial nerves: twelve paired nerves arising from the brain; the facial (VII) and trigeminal (V) nerves are most relevant to facial treatments

Danger zones: anatomical regions where arteries and veins are at higher risk during injections

Dynamic rhytids: wrinkles caused by repeated muscle movement

Ethnic variation: differences in facial bone structure, soft tissue, and pigmentation among populations

Extrinsic ageing: ageing caused by environmental factors like UV exposure and smoking

Facial artery: main artery supplying blood to the superficial facial structures

Facial nerve (VII): motor nerve controlling facial expression muscles

Fitzpatrick scale: classification of skin types by melanin content and response to UV light Gender dimorphism: anatomical differences between male and female faces (e.g., brow, jawline)

Intrinsic ageing: natural, genetically determined ageing processes

Licensed indication: use of a medical product approved by regulatory authorities for specific conditions or areas

Neuromuscular junction: site where nerve endings transmit signals to muscles, targeted by botulinum toxin

Orbicularis oculi: muscle encircling the eye, responsible for blinking and squinting

Periorbital region: area surrounding the eyes

SMAS (Superficial Musculoaponeurotic System): layer connecting facial muscles to the dermis, crucial in facial structure and movement

Static rhytids: lines visible at rest due to dermal thinning and collagen loss

Trigeminal nerve (V): major sensory nerve of the face

Vascular occlusion: blockage of a blood vessel, potentially leading to tissue necrosis or blindness in aesthetics

Volume loss: reduction in subcutaneous fat, muscle, and bone support with age

Zygomaticus major/minor: muscles responsible for lifting the corners of the mouth when smiling

Unit CO701 Assignment Questions

Question 1

You are carrying out a combined dermal filler and botulinum toxin procedures on a client who requires midface volumisation, chin refinement, and glabellar line softening. As you plan your injection sites, you consider areas where nerve injury or intraneural injection risk is highest.
During their consultation, the client asks why you have to avoid certain zones and the reason why you aspirate or adjust your needle angles in others.

Explain which sensory and motor nerve pathways of the face you must consider when injecting dermal fillers in the midface and chin, and botulinum toxin in the glabellar region. In your answer, please ensure that you identify at least two key safety zones and describe how understanding nerve pathways reduces the risk of complications.

(minimum 500 words)

Question 2

You are assessing three clients who booked in with you for aesthetic injectable procedures (botulinum toxin and dermal fillers):

1. Client A is a woman in her early sixties seeking midface revolumisation and perioral rejuvenation
2. Client B is a male in his late twenties requesting jawline contouring and subtle cheek enhancement
3. Client C is a Fitzpatrick Type VI client of African heritage in their mid-thirties, seeking undereye rejuvenation and chin projection

Analyse how variations in age, gender, ethnicity, and skin type influence your assessment, anatomical considerations, product selection, and injection planning for these three clients. Provide specific examples of how these anatomical differences impact procedure safety and the expected outcomes.

(minimum 500 words)

Question 3

A client comes into your clinic requesting procedures for pronounced dynamic forehead lines and crow’s feet. During the consultation, she expresses concern about “looking frozen” and asks how the product actually stops the muscles from moving. She also wants to understand why results are not immediate and why maintenance procedures are required.

With reference to the scenario, analyse how botulinum toxin affects neuromuscular transmission to reduce dynamic movement. In your answer, explain the key steps in the mechanism of action, why onset is delayed, how muscle weakening occurs, and why results gradually wear off over time.

(minimum 500 words)

Question 4

A client in her mid-forties comes to your clinic, she is concerned about looking “tired and tense,” particularly around her eyes and lower face. On assessment, you observe:

• overactive frontalis and orbicularis oculi muscles
• slight facial asymmetry during smiling, linked to reduced activation of the left zygomaticus
• mottled erythema across the cheeks, which worsens during emotional expression
• reduced tissue turgor and early skin laxity

She asks why her face looks more strained, uneven, and flushed compared to a few years ago, and how underlying physiology influences her appearance.

With reference to this scenario, analyse how muscle tone, nerve function, and blood flow each contribute to facial movement and appearance. Explain how alterations in these systems can influence expression, symmetry, skin quality, and visible ageing.

(minimum 500 words)

Question 5

A client in her early fifties comes to your clinic requesting a full-face rejuvenation with dermal fillers and botulinum toxin. During the consultation while checking her medical history, you note the following:

• she has hypothyroidism, controlled with levothyroxine
• she takes long-term oral corticosteroids for an autoimmune condition
• she reports intermittent statin use for
• she experiences occasional muscle weakness and easy bruising
• her skin appears thin, fragile, and dull with reduced elasticity
• facial muscle tone is slightly reduced in the midface and around the perioral region

She asks you why her skin feels thinner and why her muscles seem “weaker and less responsive” than in the past.

With reference to this scenario, evaluate how systemic medications and medical conditions may affect skin and muscle tone. In your answer, analyse how these changes could influence clinical assessment, treatment planning, and expected outcomes for cosmetic injectables.

(minimum 500 words)

Question 6

A client in her late fifties comes to your clinic for full-face rejuvenation. She reports that her upper eyelids feel “heavy,” her cheeks look “flat and saggy,” and her jawline has lost definition. On examination, you observe:

• deep horizontal forehead lines and etched crow’s feet
• mild upper-lid ptosis and brow descent
• midface volume loss with prominent nasolabial folds
• marionette lines, jowling, and reduced chin support
• skin thinning and reduced elasticity throughout the face

She asks how ageing causes these visible changes and why different parts of her face seem to age in different ways.

With reference to this scenario, correlate the underlying ageing changes with wrinkle formation, ptosis, and loss of structural support in the upper, mid, and lower face. Explain how changes in bone, fat, muscle, ligaments, and skin contribute to the client’s presentation.

(minimum 500 words)

Question 7

A woman in her late forties comes to your clinic requesting dermal filler to “lift her smile lines” and soften her nasolabial folds. On examination, you note:

• mild midface volume loss (Sub-Orbicularis Oculi Fat (SOOF) and Deep Medial Cheek Fat (DMCF) deflation)
• descent of the superficial medial cheek fat
• strong zygomatic and orbicularis retaining ligaments tethering the fold
• early jowling but minimal laxity
• thin skin around the perioral area with prominent dynamic movement
• no previous injectable procedures
• a history of bruxism causing masseter hypertrophy

She asks why you may not inject directly into the nasolabial fold and why you recommend treating areas she “wasn’t concerned about,” such as the midface.

With reference to this scenario, justify your clinical decision-making by applying knowledge of facial anatomy and the client’s presentation. Explain which areas you would treat, which you would avoid, and why, based on anatomical structure, ageing pattern, and risk profile.

(minimum 500 words)

Answer

Request Answer of this Assignment